A Study of Hormonal Therapy and Apalutamide With or Without Abiraterone Acetate and Prednisone in Newly Diagnosed Prostate Cancers
Condition:   Prostate Cancer Interventions:   Drug: Apalutamide;   Drug: Abiraterone Acetate;   Drug: Prednisone;   Procedure: Radical Prostatectomy;   Procedure: Extended Pelvic lymphadenectomy;   Drug: GnRH agonist/antagonist Sponsors:   Memorial Sloan Kettering Cancer Center;   Dana-Farber Cancer Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2018 Category: Research Source Type: clinical trials

Anti PD-L1 Antibody + Anti CTLA-4 Antibody in Combination With Hormone Therapy in Patients With Hormone Receptor Positive HER2-negative Recurrent or Metastatic Breast Cancer
Condition:   Breast Cancer Intervention:   Drug: Durvalumab,Tremelimumab,Fulvestrant Sponsor:   Kyoto Breast Cancer Research Network Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2018 Category: Research Source Type: clinical trials

Growth Hormone Therapy in Liver Cirrhosis
Condition:   Cirrhosis, Liver Interventions:   Drug: Standard Medical Therapy;   Drug: Growth Hormone Sponsor:   Postgraduate Institute of Medical Education and Research Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2018 Category: Research Source Type: clinical trials

Pilot Study Describing the Early Evolution of the Sexual Function of Patients Receiving Adjuvant Hormone Therapy for Breast Cancer
Condition:   Breast Cancer Intervention:   Other: quality of life questionnaire Sponsor:   Centre Hospitalier Departemental Vendee Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2018 Category: Research Source Type: clinical trials